INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Other Noncurrent Liabilities
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Other Noncurrent Liabilities of -$34.99 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $9.23K, a 24.61% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$66.23K, a 145.76% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $6.88K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $15.12K, a 147.22% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for fiscal 2026 was -$34.99K, a 264.23% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $21.31K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$364.15K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $28.86K, a 32.55% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$56.99K derived: sum of 2 quarters · filed 2026-08-19 | -$50.11K derived: sum of 3 quarters · filed 2026-08-19 | -$34.99K 10-K · filed 2026-08-19 |
| 2026-03-31 | -$66.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$59.34K derived: sum of 2 quarters · filed 2026-05-13 | -$44.23K 10-Q · filed 2026-05-13 | -$31.98K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $6.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | $22.00K 10-Q · filed 2026-02-12 | $34.25K derived: sum of 3 quarters · filed 2026-08-19 | $178.99K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $15.12K 10-Q · filed 2025-11-12 | $27.37K derived: sum of 2 quarters · filed 2026-08-19 | $172.10K derived: sum of 3 quarters · filed 2026-08-19 | $30.31K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $12.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $156.98K derived: sum of 2 quarters · filed 2026-08-19 | $15.19K derived: sum of 3 quarters · filed 2026-08-19 | $21.31K 10-K · filed 2026-08-19 |
| 2025-03-31 | $144.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $2.94K derived: sum of 2 quarters · filed 2026-05-13 | $9.06K 10-Q · filed 2026-05-13 | -$360.48K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$141.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$135.68K 10-Q · filed 2026-02-12 | -$505.21K derived: sum of 3 quarters · filed 2026-02-12 | -$504.92K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $6.12K 10-Q · filed 2025-11-12 | -$363.42K derived: sum of 2 quarters · filed 2025-11-12 | -$363.12K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$369.53K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$369.24K derived: sum of 2 quarters · filed 2025-08-15 | -$364.15K 10-K · filed 2025-08-15 | |
| 2024-03-31 | $293.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $5.38K 10-Q · filed 2025-05-13 | ||
| 2023-12-31 | $5.09K 10-Q · filed 2025-02-13 | |||
| 2022-12-31 | $2.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$26.93K 10-Q · filed 2023-02-14 | -$12.85K derived: sum of 3 quarters · filed 2023-02-14 | -$7.01K derived: sum of 4 quarters · filed 2023-02-14 |
| 2022-09-30 | -$29.84K 10-Q · filed 2022-11-14 | -$15.76K derived: sum of 2 quarters · filed 2022-11-14 | -$9.92K derived: sum of 3 quarters · filed 2022-11-14 | -$9.47K derived: sum of 4 quarters · filed 2023-02-14 |
| 2022-06-30 | $14.08K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $19.92K derived: sum of 2 quarters · filed 2022-09-22 | $20.36K derived: sum of 3 quarters · filed 2023-02-14 | $28.86K 10-K · filed 2022-09-22 |
| 2022-03-31 | $5.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $6.29K derived: sum of 2 quarters · filed 2023-02-14 | $14.78K 10-Q · filed 2022-05-16 | $18.42K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-12-31 | $443.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $8.94K 10-Q · filed 2023-02-14 | $12.58K derived: sum of 3 quarters · filed 2023-02-14 | $12.76K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $8.49K 10-Q · filed 2022-11-14 | $12.14K derived: sum of 2 quarters · filed 2022-11-14 | $12.32K derived: sum of 3 quarters · filed 2022-11-14 | $14.66K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $3.64K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $3.82K derived: sum of 2 quarters · filed 2022-09-22 | $6.17K derived: sum of 3 quarters · filed 2022-09-22 | $21.77K 10-K · filed 2022-09-22 |
| 2021-03-31 | $181.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $2.52K derived: sum of 2 quarters · filed 2022-05-16 | $18.13K 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $2.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $17.95K 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | $15.61K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |